Clinical trial
Recombinant Human IL-4 Receptor Used in Treatment of Asthma
NCT00017693 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00017693 |
|---|---|
| Title | Recombinant Human IL-4 Receptor Used in Treatment of Asthma |
| Official title | Phase II Efficacy Study of Aerosolized Recombinant Human IL-4 Receptor in Asthma |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Immunex Corporation Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Biological |
| Interventions | Recombinant human soluble IL-4 receptor, Placebo for Recombinant human soluble IL-4 receptor |
| Enrollment | 62 |
| Start date | May 1, 1998 |
| Primary completion | Feb 1, 2000 |
| Completion | Feb 1, 2000 |
| First posted | Aug 31, 2001 |
| Last update posted | Mar 7, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: